E
Outset Medical, Inc.
OM
$0.5781
$0.02514.54%
E
Sell
8/15/2024Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 8/15/2024 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 2.13 to 2.9.
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 8/15/2024 due to a decline in the total return index, solvency index and volatility index. Debt to equity increased from 2.13 to 2.9.
D
Sell
7/18/2024Upgraded
Outset Medical, Inc. (OM) was upgraded to D- from E+ on 7/18/2024 due to an increase in the growth index, volatility index and valuation index. EBIT increased 1.18% from -$37.35M to -$36.91M.
Outset Medical, Inc. (OM) was upgraded to D- from E+ on 7/18/2024 due to an increase in the growth index, volatility index and valuation index. EBIT increased 1.18% from -$37.35M to -$36.91M.
E
Sell
10/12/2023Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 10/12/2023 due to a decline in the total return index and volatility index.
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 10/12/2023 due to a decline in the total return index and volatility index.
D
Sell
9/27/2023Upgraded
Outset Medical, Inc. (OM) was upgraded to D- from E+ on 9/27/2023 due to an increase in the valuation index and growth index. Operating cash flow increased 37.05% from -$44.76M to -$28.18M, total revenue increased 7.69% from $33.47M to $36.04M, and earnings per share increased from -$0.9014 to -$0.9.
Outset Medical, Inc. (OM) was upgraded to D- from E+ on 9/27/2023 due to an increase in the valuation index and growth index. Operating cash flow increased 37.05% from -$44.76M to -$28.18M, total revenue increased 7.69% from $33.47M to $36.04M, and earnings per share increased from -$0.9014 to -$0.9.
E
Sell
5/11/2023Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 5/11/2023 due to a decline in the volatility index, total return index and growth index.
Outset Medical, Inc. (OM) was downgraded to E+ from D- on 5/11/2023 due to a decline in the volatility index, total return index and growth index.
D
Sell
3/14/2023Downgrade
Outset Medical, Inc. (OM) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
Outset Medical, Inc. (OM) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/14/2023Upgraded
Outset Medical, Inc. (OM) was upgraded to D from D- on 2/14/2023 due to an increase in the total return index.
Outset Medical, Inc. (OM) was upgraded to D from D- on 2/14/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
Outset Medical, Inc. (OM) was downgraded to D- from D on 2/8/2023 due to a large decline in the solvency index and valuation index. Debt to equity increased from 0.1 to 0.11, and the quick ratio declined from 5.19 to 5.04.
Outset Medical, Inc. (OM) was downgraded to D- from D on 2/8/2023 due to a large decline in the solvency index and valuation index. Debt to equity increased from 0.1 to 0.11, and the quick ratio declined from 5.19 to 5.04.
D
Sell
5/16/2022Upgraded
Outset Medical, Inc. (OM) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index and volatility index.
Outset Medical, Inc. (OM) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index and volatility index.
E
Sell
5/13/2022Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
Outset Medical, Inc. (OM) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
Outset Medical, Inc. (OM) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index, volatility index and total return index.
Outset Medical, Inc. (OM) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index, volatility index and total return index.
E
Sell
5/1/2022Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
Outset Medical, Inc. (OM) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
Outset Medical, Inc. (OM) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index and valuation index.
Outset Medical, Inc. (OM) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index and valuation index.
E
Sell
4/20/2022Downgrade
Outset Medical, Inc. (OM) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index, total return index and growth index. EBIT declined 35.37% from -$30.14M to -$40.8M, earnings per share declined from -$0.654 to -$0.8741, and operating cash flow declined 16.16% from -$28.13M to -$32.68M.
Outset Medical, Inc. (OM) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index, total return index and growth index. EBIT declined 35.37% from -$30.14M to -$40.8M, earnings per share declined from -$0.654 to -$0.8741, and operating cash flow declined 16.16% from -$28.13M to -$32.68M.
D
Sell
11/23/2021Upgraded
Outset Medical, Inc. (OM) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and valuation index.
Outset Medical, Inc. (OM) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and valuation index.
D
Sell
11/8/2021Downgrade
Outset Medical, Inc. (OM) was downgraded to D- from D on 11/8/2021 due to a major decline in the efficiency index and valuation index. Total capital declined 4.61% from $469.45M to $447.8M, and net income declined 0.87% from -$30.21M to -$30.47M.
Outset Medical, Inc. (OM) was downgraded to D- from D on 11/8/2021 due to a major decline in the efficiency index and valuation index. Total capital declined 4.61% from $469.45M to $447.8M, and net income declined 0.87% from -$30.21M to -$30.47M.
D
Sell
12/8/2020None
Outset Medical, Inc. (OM) was downgraded to D from U on 12/08/2020.
Outset Medical, Inc. (OM) was downgraded to D from U on 12/08/2020.
NASDAQ
03/17/2025 4:00PM Eastern
Quotes delayed
